Skip to main content

AusPAR: Minjuvi

Australian Public Assessment Report
Device/Product Name
Minjuvi
Active ingredients
Tafasitamab
AusPAR Date
Published
Submission Number
PM-2022-01544-1-6
Submission Type
New biological entity
Decision
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site